Skip to main content
Equibles

RAYMOND JAMES FINANCIAL INC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 720005 ST. PETERSBURG, FL
Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,454,506
+$4,330,354 QoQ
Shares Held
777,268
+5.9% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 311 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 67% Shared 0% None 33%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RAYMOND JAMES FINANCIAL INC holds $625,710,198 across 33 Drug Manufacturers - Specialty & Generic names. AMRX ranks #12 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,741,371 $125,134,918
2 NBIX
Neurocrine Biosciences Inc
 580,170 $97,781,849
3 HLN
Haleon plc
 7,278,875 $67,911,902
4 ELAN
Elanco Animal Health Inc
 2,383,479 $58,657,416
5 TEVA
Teva Pharmaceutical Industries Ltd
 1,692,660 $57,347,317
6 UTHR
UNITED THERAPEUTICS Corp
 55,173 $29,894,385
7 VTRS
Viatris Inc
 1,668,730 $26,499,430
8 LNTH
Lantheus Holdings, Inc.
 234,788 $26,047,378

All Filings in AMRX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,454,506 777,268
2026-03-31 $9,124,152 734,043
2025-12-31 $8,795,554 698,060
2025-09-30 $7,431,522 742,410
2025-06-30 $5,778,944 714,332
2025-03-31 $4,998,685 596,502
2024-12-31 $2,946,206 371,996